Tag Archives: Merck

Dec. 23, 2021 — The FDA has granted emergency use authorization to Merck’s antiviral drug to deal with adults with gentle to reasonable COVID-19 who’re in danger for extreme illness. Similar to FDA authorization of one other antiviral capsule routine — ritonavir plus nirmatrelvir, or Paxlovid — granted to Pfizer on Wednesday, molnupiravir (model identify […]